Perceptive Advisors LLC Leap Therapeutics, Inc. Transaction History

Perceptive Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.42 - $0.78 $313,173 - $581,608	-745,652 Reduced 9.98%	6,726,496 $3.03 Million
Q3 2022 Nov 14, 2022	SELL	$0.92 - $1.75 $440,956 - $838,775	-479,300 Reduced 6.03%	7,472,148 $6.58 Million
Q1 2022 May 16, 2022	SELL	$1.6 - $3.35 $840,076 - $1.76 Million	-525,048 Reduced 6.19%	7,951,448 $13.9 Million
Q2 2020 Aug 14, 2020	BUY	$1.39 - $2.84 $2.43 Million - $4.97 Million	1,750,000 Added 26.02%	8,476,496 $17.5 Million
Q1 2020 May 15, 2020	BUY	$1.06 - $2.94 $7.13 Million - $19.8 Million	6,726,496 New	6,726,496 $10.6 Million

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $198M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.